A Food Effect Study of CT-L01 After Oral Administration in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 9, 2022

Primary Completion Date

July 19, 2022

Study Completion Date

July 25, 2022

Conditions

Healthy

Interventions

DRUG

CT-L01 12.5/1,000 mg

FDC tablet, 2 tablets at a time, oral administration, dosing under fasting condition

DRUG

CT-L01 12.5/1,000 mg

FDC tablet, 2 tablets at a time, oral administration, dosing after high-fat meal

Trial Locations (1)

Chungnam National University Hospital, Daejeon